Sca-1+ cardiac progenitor cell therapy with cells overexpressing integrin-linked kinase improves cardiac function after myocardial infarction

Transplantation

Volumn 95, Issue 10, 2013, Pages 1187-1196

  Ling, Lin ^a   Bai, Jian ^a   Gu, Rong ^a   Jiang, Chunying ^a   Li, Ran ^a   Kang, Lina ^a   Ferro, Albert ^b   Xu, Biao ^a  

^a NANJING UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Integrin linked kinase; Myocardial infarction; Sca 1+ cardiac progenitor cells

Indexed keywords

CYCLIN D1; GREEN FLUORESCENT PROTEIN; INTEGRIN LINKED KINASE; PROTEIN CDC42; PROTEIN KINASE B; STEM CELL ANTIGEN 1; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INDUCTION; EXERCISE; GENE OVEREXPRESSION; GENE TARGETING; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; IN VITRO STUDY; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIGENS, LY; APOPTOSIS; BODY WEIGHT; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN-SERINE-THREONINE KINASES; STEM CELL TRANSPLANTATION;

EID: 84878574946     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31828a9423     Document Type: Article

References (40)

1. Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107.
2. Qiao H, Zhang H, Yamanaka S, et al. Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes. Circ Cardiovasc Imag 2011; 4: 33.
3. Zhang S, Jia Z, Ge J, et al. Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transplant 2005; 14: 787.
4. Zhao M, Barron MR, Li Z, et al. Making stem cells infarct avid. Cell Transplant 2010; 19: 245.
5. Barile L, Messina E, Giacomello A, et al. Endogenous cardiac stem cells. Prog Cardiovasc Dis 2007; 50: 31.
6. Tang YL, Shen L, Qian K, et al. A novel two-step procedure to expand cardiac Sca-1+ cells clonally. Biochem Biophys Res Commun 2007; 359: 877.
7. Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004; 279: 11384.
8. Wang X, Hu Q, Nakamura Y, et al. The role of the Sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 2006; 24: 1779.
9. Westrich J, Yaeger P, He C, et al. Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium. Cell Transplant 2010; 19: 937.
10. LiW, Ma N, Ong LL, et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007; 25: 2118.
11. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195.
12. Matsumoto R, Omura T, Yoshiyama M, et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscl Throm Vas 2005; 25: 1168.
13. Hannigan GE, Coles JG, Dedhar S. Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ Res 2007; 100: 1408.
14. Dedhar S. Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol 2000; 12: 250.
15. Hannigan GE, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 2005; 5: 51.
16. Ding L, Dong L, Chen X, et al. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation 2009; 120: 764.
17. Lloyd Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statisticsV2010 update: a report from the American Heart Association. Circulation 2010; 121:e46.
18. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763.
19. Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiospherederived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007; 115: 896.
20. Pouzet B, Vilquin JT, Hagege AA, et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 2001; 71: 844.
21. Robey TE, Saiget MK, Reinecke H, et al. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 2008; 45: 567.
22. Zhang M, Methot D, Poppa V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001; 33: 907.
23. Gao LR, Zhang NK, Bai J, et al. The apelin-APJ pathway exists in cardiomyogenic cells derived from mesenchymal stem cells in vitro and in vivo. Cell Transplant 2010; 19: 949.
24. Song SW, Chang W, Song BW, et al. Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells 2009; 27: 1358.
25. Tang J, Wang J, Kong X, et al. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway. Exp Cell Res 2009; 315: 3521.
26. Wickstrom SA, Lange A, Montanez E, et al. The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase! EMBO J 2010; 29: 281.
27. White DE, Coutu P, Shi YF, et al. Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev 2006; 20: 2355.
28. Bock Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004; 432: 466.
29. Bendig G, Grimmler M, Huttner IG, et al. Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart. Genes Dev 2006; 20: 2361.
30. Fujio Y, Nguyen T, Wencker D, et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000; 101: 660.
31. Hannigan GE, McDonald PC, Walsh MP, et al. Integrin-linked kinase: not so 'pseudo' after all. Oncogene 2011; 30: 4375.
32. Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta 2007; 1775: 163.
33. Capetanaki Y, Bloch RJ, Kouloumenta A, et al. Muscle intermediate filaments and their links to membranes and membranous organelles. Exp Cell Res 2007; 313: 2063.
34. Nagai T, Tanaka Ishikawa M, Aikawa R, et al. Cdc42 plays a critical role in assembly of sarcomere units in series of cardiac myocytes. Biochem Biophys Res Commun 2003; 305: 806.
35. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81: 53.
36. Rigol M, Solanes N, Farre J, et al. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. J Card Fail 2010; 16: 357.
37. Moscoso I, Barallobre J, de Ilarduya OM, et al. Analysis of different routes of administration of heterologous 5-azacytidine-treated mesenchymal stem cells in a porcine model of myocardial infarction. Transplant Proc 2009; 41: 2273.
38. Henning RJ, Burgos JD, Vasko M, et al. Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size. Cell Transplant 2007; 16: 907.
39. Zhang Y, Sievers RE, Prasad M, et al. Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction. Cardiovasc Pathol 2011; 20: 204.
40. Swijnenburg RJ, Govaert JA, van der Bogt KE, et al. Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction. Circ Cardiovasc Imag 2010; 3: 77.